Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4
- PMID: 12972635
- PMCID: PMC208816
- DOI: 10.1073/pnas.1934747100
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4
Abstract
The predominant mode of HIV transmission worldwide is via heterosexual contact, with the cervico-vaginal mucosa being the main portal of entry in women. The cervico-vaginal mucosa is naturally colonized with commensal bacteria, primarily lactobacilli. To address the urgent need for female-controlled approaches to block the heterosexual transmission of HIV, we have engineered natural human vaginal isolates of Lactobacillus jensenii to secrete two-domain CD4 (2D CD4) proteins. The secreted 2D CD4 recognized a conformation-dependent anti-CD4 antibody and bound HIV type 1 (HIV-1) gp120, suggesting that the expressed proteins adopted a native conformation. Single-cycle infection assays using HIV-1HxB2 carrying a luciferase reporter gene demonstrated that Lactobacillus-derived 2D CD4 inhibited HIV-1 entry into _target cells in a dose-dependent manner. Importantly, coincubation of the engineered bacteria with recombinant HIV-1HxB2 reporter virus led to a significant decrease in virus infectivity of HeLa cells expressing CD4-CXCR4-CCR5. Engineered lactobacilli also caused a modest, but statistically significant, decrease in infectivity of a primary isolate, HIV-1JR-FL. This represents an important first step toward the development of engineered commensal bacteria within the vaginal microflora to inhibit heterosexual transmission of HIV.
Figures
Similar articles
-
Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus.AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):964-971. doi: 10.1089/AID.2015.0378. Epub 2016 Apr 13. AIDS Res Hum Retroviruses. 2016. PMID: 26950606 Free PMC article.
-
Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 molecules.Appl Environ Microbiol. 2008 Aug;74(15):4626-35. doi: 10.1128/AEM.00104-08. Epub 2008 Jun 6. Appl Environ Microbiol. 2008. PMID: 18539799 Free PMC article.
-
Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N.Antimicrob Agents Chemother. 2006 Oct;50(10):3250-9. doi: 10.1128/AAC.00493-06. Antimicrob Agents Chemother. 2006. PMID: 17005802 Free PMC article.
-
An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli.AIDS. 2006 Oct 3;20(15):1917-22. doi: 10.1097/01.aids.0000247112.36091.f8. AIDS. 2006. PMID: 16988512
-
Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.J Antimicrob Chemother. 2013 Sep;68(9):2026-37. doi: 10.1093/jac/dkt152. Epub 2013 May 2. J Antimicrob Chemother. 2013. PMID: 23640125
Cited by
-
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers.Sci Rep. 2018 Jan 30;8(1):1890. doi: 10.1038/s41598-018-20300-9. Sci Rep. 2018. PMID: 29382912 Free PMC article.
-
Rational design of improved pharmabiotics.J Biomed Biotechnol. 2009;2009:275287. doi: 10.1155/2009/275287. Epub 2009 Sep 10. J Biomed Biotechnol. 2009. PMID: 19753318 Free PMC article. Review.
-
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.Mucosal Immunol. 2011 Nov;4(6):648-57. doi: 10.1038/mi.2011.30. Epub 2011 Jul 6. Mucosal Immunol. 2011. PMID: 21734653 Free PMC article.
-
Advances in HIV microbicide development.Future Med Chem. 2011 Dec;3(16):2101-16. doi: 10.4155/fmc.11.153. Future Med Chem. 2011. PMID: 22098355 Free PMC article. Review.
-
Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus.AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):964-971. doi: 10.1089/AID.2015.0378. Epub 2016 Apr 13. AIDS Res Hum Retroviruses. 2016. PMID: 26950606 Free PMC article.
References
-
- Royce, R. A., Sena, A., Cates, W., Jr., & Cohen, M. S. (1997) N. Engl. J. Med. 336, 1072–1078. - PubMed
-
- al-Nozha, M., Ramia, S., al-Frayh, A. & Arif, M. (1990) J. Acquired Immune Defic. Syndr. 3, 193–194. - PubMed
-
- Redondo-Lopez, V., Cook, R. L. & Sobel, J. D. (1990) Rev. Infect. Dis. 12, 856–872. - PubMed
-
- Taha, T. E., Hoover, D. R., Dallabetta, G. A., Kumwenda, N. I., Mtimavalye, L. A., Yang, L. P., Liomba, G. N., Broadhead, R. L., Chiphangwi, J. D. & Miotti, P. G. (1998) AIDS 12, 1699–1706. - PubMed
-
- Antonio, M. A., Hawes, S. E. & Hillier, S. L. (1999) J. Infect. Dis. 180, 1950–1956. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials